FP593REAL-WORLD SAFETY AND EFFECTIVENESS OF SUCROFERRIC OXYHYDROXIDE IN DIALYSIS PATIENTS: AN INTERIM ANALYSIS OF THE VERIFIE STUDY

Authors:

Abstract
INTRODUCTION AND AIMS: Sucroferric oxyhydroxide (SFOH) is a non-calcium-, iron-based phosphate binder (PB) indicated for the treatment of hyperphosphataemia in dialysis patients. The VERIFIE (Velphoro Evaluation of Real-lIfe saFety, effectIveness and adherencE) study is evaluating the safety and effectiveness of SFOH in dialysis patients in routine clinical practice.